Gene Therapy
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 5.9 | Q1 | 86.5% | 1.502 | Q1 | 92.0% |
| 2024 | 4.5 | Q1 | 84.3% | 1.784 | Q1 | 94.3% |
| 2023 | 4.6 | Q2 | 74.8% | 1.671 | Q1 | 94.0% |
| 2022 | 5.1 | Q1 | 73.6% | 1.366 | Q1 | 91.9% |
| 2021 | 4.2 | Q3 | 64.2% | 0.927 | Q2 | 84.9% |
| 2020 | — | — | 1.332 | Q2 | 90.8% | |
| 2019 | — | — | 1.340 | Q2 | 91.0% | |
| 2018 | — | — | 1.313 | Q2 | 89.6% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1476-5462
ISSN
0969-7128
country
GBcoverage
1994-2026